UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2363-2364

2020

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Clinical infectious diseases, 2020-11, Vol.71 (16), p.2294-2297

2020

Volltextzugriff (PDF)

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Clinical infectious diseases, 2015-09, Vol.61 (5), p.730-740

2015

Volltextzugriff (PDF)

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Clinical infectious diseases, 2020-10, Vol.71 (7), p.e115-e124

2020

Volltextzugriff (PDF)

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2016-03, Vol.62 (6), p.683-694

2016

Volltextzugriff (PDF)

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Clinical infectious diseases, 2021-08, Vol.73 (3), p.468-477

2021

Volltextzugriff (PDF)

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

The Journal of infectious diseases, 2016-12, Vol.214 (12), p.1965-1974

2016

Volltextzugriff (PDF)

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2355-2365

2020

Volltextzugriff (PDF)

Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2172-e2174

2021

Volltextzugriff (PDF)

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

Clinical infectious diseases, 2020-12, Vol.71 (9), p.2354-2362

2020

Volltextzugriff (PDF)

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3349-e3354

2021

Volltextzugriff (PDF)

Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012–2013

Clinical infectious diseases, 2016-10, Vol.63 (7), p.976-983

2016

Volltextzugriff (PDF)

From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients

Clinical infectious diseases, 2017-03, Vol.64 (5), p.685-691

2017

Volltextzugriff (PDF)

Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers

Clinical infectious diseases, 2020-02, Vol.70 (5), p.789-797

2020

Volltextzugriff (PDF)

Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression

Clinical infectious diseases, 2021-08, Vol.73 (4), p.e997-e1003

2021

Volltextzugriff (PDF)

Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial

Clinical infectious diseases, 2023-10, Vol.77 (7), p.1012-1020

2023

Volltextzugriff (PDF)

Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1263-1268

2020

Volltextzugriff (PDF)

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Clinical infectious diseases, 2017-01, Vol.64 (1), p.44-52

2017

Volltextzugriff (PDF)

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial

Clinical infectious diseases, 2019-07, Vol.69 (2), p.207-214

2019

Volltextzugriff (PDF)

No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project

Clinical infectious diseases, 2018-06, Vol.66 (12), p.1899-1909

2018

Volltextzugriff (PDF)

Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs

Clinical infectious diseases, 2021-12, Vol.73 (11), p.2093-2100

2021

Volltextzugriff (PDF)

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C—Associated Liver Cirrhosis

Clinical infectious diseases, 2013-07, Vol.57 (2), p.230-236

2013

Volltextzugriff (PDF)

Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response

Clinical infectious diseases, 2020-03, Vol.70 (6), p.1208-1214

2020

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(103)

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(103)
Science & Technology
(103)
Sustained Virologic Response
(103)
Humans
(96)
Infectious Diseases
(95)
Microbiology
(94)
Immunology
(83)
Male
(69)
Female
(64)
Middle Aged
(56)
Antiviral Agents - Therapeutic Use
(53)
Hepatitis C, Chronic - Drug Therapy
(46)
Adult
(45)
Hiv Infections - Drug Therapy
(36)
Hiv
(34)
Hepatitis C
(31)
Hepatitis
(29)
Aged
(27)
Hepatitis C - Drug Therapy
(26)
Treatment Outcome
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet

Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?

Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis

Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012–2013

From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients

Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers

Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression

Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication

Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial

Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial

No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project

Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C—Associated Liver Cirrhosis

All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort

Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response

Aktive Filter

Suchergebnisse filtern